Ginkgo Bioworks Holdings (DNA) Amortizatization of Intangibles (2022 - 2026)

Ginkgo Bioworks Holdings (DNA) reported Amortizatization of Intangibles of $7.1 million for Q1 2026, down 3.59% on a YoY basis from $7.4 million in Q1 2025, and down 6.8% quarter-over-quarter from $7.6 million in Q4 2025.

Ginkgo Bioworks Holdings (DNA) Amortizatization of Intangibles (2022 - 2026) Analysis & Trends

Ginkgo Bioworks Holdings has reported Amortizatization of Intangibles for 5 years, with the latest figure at $7.1 million in Q1 2026.

  • For the quarter ending Q1 2026, Amortizatization of Intangibles fell 3.59% year-over-year to $7.1 million; the trailing twelve-month figure through Mar 2026 stood at $29.8 million (changed 0.07% YoY), and the FY2025 full-year result was $30.1 million, up 7.07% from the prior year.
  • Amortizatization of Intangibles for Q1 2026 stood at $7.1 million, down from $7.6 million in the prior quarter.
  • The five-year high for Amortizatization of Intangibles was $10.9 million in Q3 2022, with the low at $3.7 million in Q4 2023.
  • Historically, Amortizatization of Intangibles has averaged $7.4 million across 5 years, with a median of $7.5 million in 2025.
  • Annual changes were most pronounced in 2023 — Amortizatization of Intangibles plunged 48.95% — and 2024, when it soared 103.26%.
  • Ginkgo Bioworks Holdings' Amortizatization of Intangibles stood at $7.2 million in 2022, then slumped by 48.95% to $3.7 million in 2023, then soared by 103.26% to $7.5 million in 2024, then increased by 2.1% to $7.6 million in 2025, then retreated by 6.8% to $7.1 million in 2026.
  • The last three Amortizatization of Intangibles figures came in at $7.1 million (Q1 2026), $7.6 million (Q4 2025), and $7.6 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Alterity Therapeutics 814,307.08 Bn 814,307.05 Bn - -
2 Belite Bio 55,320.00 Bn 55,320.00 Bn - -
3 Quantum Biopharma 17,149.72 Bn 17,149.72 Bn - 13,267.00
4 Legend Biotech 3,590.00 Bn 3,589.71 Bn 242.10 Mn -
5 Akari Therapeutics 1,650.72 Bn 1,650.72 Bn - -
6 Evaxion A 1,522.09 Bn 1,522.07 Bn - -
7 Psyence Biomedical 229.39 Bn 229.38 Bn - -
8 Vertex Pharmaceuticals 113.09 Bn 105.85 Bn 2.59 Bn -
9 Abivax 90.15 Bn 90.15 Bn - -
10 Ginkgo Bioworks Holdings 466.98 Mn 466.98 Mn 16.38 Mn 7.11 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 7.11 Mn
Mar 31, 2026 7.11 Mn
Dec 31, 2025 7.63 Mn
Dec 31, 2025 7.63 Mn
Sep 30, 2025 7.58 Mn
Sep 30, 2025 7.58 Mn
Jun 30, 2025 7.49 Mn
Jun 30, 2025 7.49 Mn
Mar 31, 2025 7.38 Mn
Mar 31, 2025 7.38 Mn
Dec 31, 2024 7.48 Mn
Dec 31, 2024 7.48 Mn
Sep 30, 2024 7.55 Mn
Sep 30, 2024 7.55 Mn
Jun 30, 2024 7.43 Mn
Jun 30, 2024 7.43 Mn
Mar 31, 2024 5.64 Mn
Mar 31, 2024 5.64 Mn
Dec 31, 2023 3.68 Mn
Dec 31, 2023 3.68 Mn